ABCL
Price
$2.72
Change
-$0.17 (-5.88%)
Updated
Nov 5 closing price
111 days until earnings call
CARM
Price
$1.10
Change
+$0.05 (+4.76%)
Updated
Nov 5 closing price
Ad is loading...

ABCL vs CARM

Header iconABCL vs CARM Comparison
Open Charts ABCL vs CARMBanner chart's image
AbCellera Biologics
Price$2.72
Change-$0.17 (-5.88%)
Volume$3.84M
CapitalizationN/A
Carisma Therapeutics
Price$1.10
Change+$0.05 (+4.76%)
Volume$216.55K
CapitalizationN/A
View a ticker or compare two or three
ABCL vs CARM Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABCL vs. CARM commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongSell and CARM is a StrongBuy.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (ABCL: $2.72 vs. CARM: $1.10)
Brand notoriety: ABCL and CARM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 193% vs. CARM: 168%
Market capitalization -- ABCL: $803.4M vs. CARM: $45.7M
ABCL [@Biotechnology] is valued at $803.4M. CARM’s [@Biotechnology] market capitalization is $45.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCARM’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CARM’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CARM’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • CARM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CARM is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -3.89% price change this week, while CARM (@Biotechnology) price change was +8.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.94%. For the same industry, the average monthly price growth was +11.15%, and the average quarterly price growth was +8.66%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

CARM is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Biotechnology (-0.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($803M) has a higher market cap than CARM($45.7M). ABCL YTD gains are higher at: -52.364 vs. CARM (-62.457). CARM has higher annual earnings (EBITDA): -72.61M vs. ABCL (-195.18M). ABCL has more cash in the bank: 670M vs. CARM (40.4M). CARM has less debt than ABCL: CARM (8.17M) vs ABCL (72.1M). ABCL has higher revenues than CARM: ABCL (33.1M) vs CARM (20.7M).
ABCLCARMABCL / CARM
Capitalization803M45.7M1,757%
EBITDA-195.18M-72.61M269%
Gain YTD-52.364-62.45784%
P/E RatioN/AN/A-
Revenue33.1M20.7M160%
Total Cash670M40.4M1,658%
Total Debt72.1M8.17M883%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCARM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CARM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMXSX8.250.10
+1.23%
Federated Hermes Max-Cap Index Svc
NBFAX29.960.30
+1.01%
Neuberger Berman Focus Adv
CDIVX14.060.14
+1.01%
Copeland Dividend Growth Fund Class I
FSENX59.260.40
+0.68%
Fidelity Select Energy Portfolio
NRGEX68.31N/A
N/A
Neuberger Berman Genesis E

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with DNA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-5.88%
DNA - ABCL
57%
Loosely correlated
+4.72%
VCYT - ABCL
56%
Loosely correlated
+2.72%
PRME - ABCL
55%
Loosely correlated
+5.56%
ADPT - ABCL
54%
Loosely correlated
+6.08%
ARVN - ABCL
54%
Loosely correlated
+0.37%
More